Nutritional-pharmacological interactions were studied in a group of malnourished subjects. Antipyrine was used to evaluate mixed-function oxidase in man. The results indicated that the rate of disappearance of antipyrine from plasma was strongly influenced by the nutritional status of the individual. The half life of antipyrine was modified in undernourished subjects and those with nutritional oedema.
Introduction
The nutritional status of an individual may affect his drug metabolism. The activity of the drug metabolising enzymes located in the microsomal fraction of the liver is important in determining blood and tissue concentrations of drugs. Many reports suggest that malnutrition, which is prevalent in the developing countries, may lead to changes in the activity of mixed-function oxidases.1 2 Most of these studies have been done in animals, however, and studies evaluating the capacity of malnourished human subjects to metabolise drugs are scanty. Poskitt3 recently reviewed studies on the clinical problems related to the use of drugs in malnutrition. Abnormalities in the structure and function of the endoplasmic reticulum, consequent on malnutrition, may be expected to change drug metabolism in man. We have already reported that the plasma half life of tetracycline is significantly changed in undernourished people.4 But tetracycline is an antibiotic that does not undergo biotransformation. We therefore considered it possible that drugs that are metabolised by the microsomal enzymes may behave differently in malnourished subjects.
We evaluated the microsomal enzyme systems in man using antipyrine half life as an index of drug metabolism. Antipyrine is widely used to predict the metabolism of drugs in man, since it is rapidly and almost completely absorbed from the gastrointestinal tract, is slowly metabolised (60/ per hour), and only the major metabolite-4-hydroxy antipyrine-is excreted in urine.5 Also, less than 10% of the parent drug is bound to plasma proteins, and hence the kinetics are not likely to be seriously affected by changes in plasma protein concentrations.
Results
The anthropometric data and serum albumin concentrations are indicated in table I. The mean weight in the controls was 58-0 kg, whereas mean weights in the malnourished subjects in groups 3 and 4 were 42 kg and 39 kg respectively. The heights of the subjects were similar, thus modifying the weight:height ratio. In normal subjects the ratio was over 0 20. In the undernourished subjects and those with nutrition oedema it was only 0-15, indicating the considerable weight deficit. Sirnilarly, serum albumin concentrations were significantly different in the control and experimental groups, the patients with nutritional oedema having the lowest concentrations. The rate of decline of antipyrine in plasma was about 6 2% per hour in normal non-smokers, 7-81"/hour in smokers, about 9%0/hour in undernourished subjects, and 570 0/hour in patients with nutritional oedema. While analysing the data pooled variations between groups were taken into consideration and the differences between individuals (probably genetic) were not excluded from the total variation. half life in normal subjects (11-22 hours) or undernourished subjects (8-6 hours). Four of the 15 subjects had a half life of over 16 hours, which was the highest value we encountered in the controls. The mean half life in patients with nutritional oedema was, however, comparable to that of normal subjects.
Discussion
There is no general biochemical test to detect slow drug metabolisers. The normal laboratory tests used to assess liver function are of little value in predicting the capacity of an individual to metabolise drugs. The current trend in drug treatment is towards fitting treatment to the individual, and it is therefore essential to study the kinetics of drug elimination. An effective regimen may then be designed.7 We therefore attempted to determine the capacity of the liver in malnourished subjects to handle drugs.
The liver is the major organ responsible for drug metabolism and consequently for drug disposition and elimination. Hence hepatic disease obviously affects drug kinetics. 8 The clinical implications of such changes are obvious. Vessel et a19 have shown that there is interindividual variation in drug metabolism, as indicated by antipyrine and phenylbutazone metabolism. Our results confirm their finding. Despite individual variations, however, there were significant differences between the groups we studied.
Smokers clear antipyrine faster than non-smokers. Both nicotine and alcohol stimulate the microsomal enzymes. 10 Recently Vestel et all' showed that caffeine and cigarette use are positively correlated with the rate of antipyrine metabolism in human subjects. Our data confirm this finding. Drug metabolism seems to be about 15-200o faster in smokers, probably because of enzyme induction by nicotine. The half life of antipyrine was also short in our undernourished subjects, who were smokers and drank alcohol. Some of the subjects in this group were agricultural labourers, and careful questioning disclosed that some were exposed to pesticides as well. Kolmodin et all showed that the plasma half life of antipyrine in workers exposed to chlorinated hydrocarbons is significantly low. The half life of antipyrine reflects the metabolic capacity of the hepatocytes and is not influenced by plasma protein binding or hepatic drug delivery rate. Therefore the antipyrine clearance rates in our subjects indicated each individual's capacity to metabolise drugs.
Although a diuretic had been given to the patients with nutritional oedema before the study, some degree of expansion of the extracellular fluid volume remained. Nevertheless, Reidenberg et a116 have shown that the metabolism of antipyrine and tolbutamide is not changed in obese fasting subjects despite significant changes in body water. The prolonged half life seen in patients with nutritional oedema was therefore unlikely to have been due to changes in body water. This view was also supported by the observations that relative volume distribution was similar in all the groups investigated.
These changes in the metabolism of antipyrine in malnourished subjects indicate that in certain conditions drug regimens may have to be changed. A reduction in half life may call for more frequent administration of drugs. On the other hand, if microsomal enzyme activity is impaired, and the half life prolonged, patients may be at a greater risk of accumulating potent drugs.
